This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Glucuronolactone Market

Market Insights on Glucuronolactone covering sales outlook, demand forecast & up-to-date key trends

Glucuronolactone Market by End-use, Form & Region - Forecast 2022 – 2032

Glucuronolactone Market Outlook (2022-2032)

[306 Pages Report]The global glucuronolactone market is estimated to reach a market valuation of USD 350.1 Mn by the year 2022, accelerating with a CAGR of 5.9% by 2022-2032. Glucuronolactone market is used as a food additive in food and functional beverages. In terms of purity, 0.99% grade of Glucuronolactone is highly preferable among manufacturers. Increasing consumption of energy drinks is one of the key factors fuelling the demand for Glucuronolactone in the market.

Glucuronolactone Market Size (2022E)

USD 350.1 Mn

Glucuronolactone Market Projected Size (2032F)

USD 624.0 Mn

Value CAGR (2022-2032)

5.9%

Top 3 Countries’ Market Share

38.4%

Glucuronolactone is an odorless, white solid substance found in people, animals, and the gums of plants. It is a vital component of all linked tissues. It is a chemical created by the human liver's glucose metabolism. Glucuronolactone is a component of connective tissues as well as an important antioxidant in the production of ascorbic acid.

Because of its numerous health benefits, the increasing adoption of glucuronolactone from various end-use industries such as pharmaceuticals and food and beverages is a significant factor contributing to the growth glucuronolactone market. Some factors expected to drive the glucuronolactone market during the forecast period include increased use of glucuronolactone as an ingredient in functional foods and energy drinks to act as a potent antioxidant and eliminate harmful chemicals through waste from the body, fueled by increased consumer health awareness.

Customize this Report

Let us know your requirement to get
100% FREE customization

Glucuronolactone Market Historic and Future Outlook Compare

Glucuronolactone sales grew at a CAGR of 5.4% between 2017 and 2022. The period marked the entry of various market players and product innovations.

In pharmaceuticals, glucuronolactone is frequently used as a component in the production of a range of treatment options for food and drug poisoning, hepatitis, and immune response modulation. A rise in demand from bodybuilders and athletes is also expected to contribute to market expansion.

High glucuronolactone prices, as well as various negative impacts related to excessive glucuronolactone intakes, such as dizziness, disorientation, and fast heartbeat, are anticipated to hamper the market growth during the forecast period.

Glucuronolactone Market Download Report Brochure

Glucuronolactone-Based Dietary Supplements Are Becoming More Popular

The human brain, liver, and heart contain glucuronolactone, which is involved in a range of physiological functions. Some of its metabolic roles include osmoregulation, membrane stability, and bile acid conjugation. Cardiovascular disease, retinal degeneration, and epilepsy are all diseases that can be caused by glucuronolactone shortage.

Glucuronolactone supplementation has been demonstrated to be beneficial to one's health. This indeed is increasing the demand for dietary supplements around the world as people grow more concerned about their health.

Furthermore, this has increased demand for glucuronolactone-containing supplements, resulting in market expansion. The rise in demand from the pharmaceutical and food & beverage industries, as well as increased awareness about a healthy lifestyle, are two major factors driving the glucuronolactone market.

However, glucuronolactone's unfavorable health effects may limit total market growth in the coming years. Furthermore, the pharmaceutical industry is predicted to grow at the quickest CAGR in the next years as people become more concerned about their health.

Nandini Roy Choudhury
Nandini Roy Choudhury
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Glucuronolactone-Based Dietary Supplements Are Becoming More Popular

The human brain, liver, and heart contain glucuronolactone, which is involved in a range of physiological functions. Some of its metabolic roles include osmoregulation, membrane stability, and bile acid conjugation. Cardiovascular disease, retinal degeneration, and epilepsy are all diseases that can be caused by glucuronolactone shortage.

Glucuronolactone supplementation has been demonstrated to be beneficial to one's health. This indeed is increasing the demand for dietary supplements around the world as people grow more concerned about their health.

Furthermore, this has increased demand for glucuronolactone-containing supplements, resulting in market expansion. The rise in demand from the pharmaceutical and food & beverage industries, as well as increased awareness about a healthy lifestyle, are two major factors driving the glucuronolactone market. However, glucuronolactone's unfavorable health effects may limit total market growth in the coming years.

Furthermore, the pharmaceutical industry is predicted to grow at the quickest CAGR in the next years as people become more concerned about their health.

Country-wise Insights

Sales of Glucuronolactone in the US

The US accounted for 89.4% of the total market in 2022 in North America and is expected to rise significantly due to the widespread use of glucuronolactone as a nutritional supplement in the country.

Additionally, glucuronolactone-containing drinks have been very popular in the country, and companies like Rockstar Inc., Red Bull, and Monster have released numerous glucuronolactone-containing drinks, which will offer enormous potential throughout the projected period. However, due to restrictions on the use of glucuronolactone in traditional beverages, the majority of these drinks are sold as supplements.

Consumption of Glucuronolactone in the United Kingdom

The use of glucuronolactone in prescription medications for the treatment of collagen disease, hepatitis, and bone illnesses in the United Kingdom, and Europe is predicted to increase at a CAGR of 6.9% from 2022 to 2032. In addition, government backing, together with increased R&D expenditure, is predicted to contribute significantly to market growth.

Rising Demand for Glucuronolactone in China

The high number of glucuronolactone producers in China and the high level of exports are expected to increase at a CAGR of 7.8% from 2022 to 2032. Furthermore, the product's widespread availability in China is projected to benefit the market in the approaching years. The pharmaceutical industry in China, India, Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam is expanding.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Category-wise Insights

Glucuronolactone Application in Pharmaceuticals Accounting for a Prominent Share

As a result of the increased application of glucuronolactone-based pills and supplements to treat hepatocirrhosis, arthritis, and hepatitis, the pharmaceutical application will rise at the fastest rate, with a CAGR of 7.0% from 2022 to 2032. Furthermore, market growth is likely to be fueled by the recovery of the pharmaceutical industry in the United States over the forecast period.

Powder Form of Glucuronolactone Accounting for Significant Share

The powder form of glucuronolactone is projected to account for the highest significant share as consumers are consuming it as a dietary supplement over the projection period, a growing health-conscious population in the urban area is expected to boost demand growth for powder glucuronolactone.

Competitive Landscape

Some of the key players operating in the glucuronolactone market are Shaoxing Marina Biotechnology Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Functional Food chem International Corporation, Merck Millipore Corporation, Jungbunzlauer, Shandong Fuyuan Bio-Tech CO.LTD. Roquette Frères, Shandong Xinhong Pharmaceutical Co., Ltd., Shandong Baisheng Biotechnology Co., Ltd., and others.

Scope of the Report

Attribute

Details

Forecast Period

2022-2032

Historical Data Available for

2017-2021

Market Analysis

USD Mn for Value and Metric Ton for Volume

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa

Key Countries Covered

United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Singapore, Australia, New Zealand, GCC countries, North Africa, South Africa, others.

Key Segments Covered

End-use, Form and Region

Key Companies Profiled

  • Shaoxing Marina Biotechnology Co.Ltd.
  • Hubei Yitai Pharmaceutical Co.Ltd.
  • Merck Millipore Corporation
  • Anhui Fubore Pharmaceutical & Chemical Co.Ltd.
  • Functional Food chem International Corporation
  • Jungbunzlauer
  • Shandong Fuyuan Bio-Tech CO.LTD.
  • Roquette Frères
  • Shandong Xinhong Pharmaceutical Co., Ltd.
  • Shandong Baisheng Biotechnology Co., Ltd.
  • Ceto Coorporation
  • Creative Compound
  • Foodchem International
  • Merck Millipore
  • Others (on additional request)

Report Coverage

Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Glucuronolactone Market by Category

By Form, Glucuronolactone Market is Segmented as:

  • Powder
  • Liquid
  • Tablet & Capsules

By End Use, Glucuronolactone Market is Segmented as:

  • Dietary Supplement
  • Energy Drinks
  • Pharmaceuticals
  • Cosmetics
  • Functional Food

By Region, Glucuronolactone Market is Segmented as:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa

Frequently Asked Questions

The glucuronolactone market will reach nearly USD 350.1 Mn by 2022.

The glucuronolactone market is anticipated to reach a valuation of USD 624.0 Mn by 2032 end.

The glucuronolactone market is expected to register a 5.9% CAGR between 2022 and 2032.

Demand for glucuronolactone in North America countries is anticipated to drive the demand during the forecast period of 2022 to 2032.

A few of the key players in the market are Shaoxing Marina Biotechnology Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Merck Millipore Corporation, Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Functional Food chem International Corporation, Jungbunzlauer, Shandong Fuyuan Bio-Tech CO.LTD. Roquette Frères, Shandong Xinhong Pharmaceutical Co., Ltd., and Shandong Baisheng Biotechnology Co., Ltd. among Others.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Product launches & Recent Developments

    3.4. Product Life Cycle Analysis

    3.5. Value Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. % of Operating Margin Analysis

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Global Drinkable Yogurt Market - Pricing Analysis

        3.6.1. Price Point Assessment by Region 

        3.6.2. Price Point Assessment by Product Type

        3.6.3. Price Forecast till 2032

        3.6.4. Factors affecting Pricing

    3.7. Forecast Factors - Relevance & Impact

    3.8. Regulatory Landscape

        3.8.1. Packaging & Labelling Regulations

        3.8.2. Certifications and Certifying Agency Overview

        3.8.3. Import/Export Policies

    3.9. Regional Parent Market Outlook

    3.10. Consumers Survey Analysis

    3.11. Macro-Economic Factors

    3.12. Product Claims & Nutritional Information Scan by Buyers

4. Global Glucuronolactone Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) & Volume (MT) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Form 

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Form , 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Form , 2022-2032

        5.3.1. Powder

        5.3.2. Liquid

        5.3.3. tablet & Capsules

    5.4. Y-o-Y Growth Trend Analysis By Form , 2017-2021

    5.5. Absolute $ Opportunity Analysis By Form , 2022-2032

6. Global Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By End Use Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By End Use Application, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By End Use Application, 2022-2032

        6.3.1. Dietary Supplements 

        6.3.2. Pharmaceutical

        6.3.3. Cosmetics

        6.3.4. Energy Drinks

        6.3.5. Food ( tofu, meat products, etc.)

    6.4. Y-o-Y Growth Trend Analysis By End Use Application, 2017-2021

    6.5. Absolute $ Opportunity Analysis By End Use Application, 2022-2032

7. Global Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Region, 2017-2021

    7.3. Current Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. East Asia

        7.3.5. South Asia

        7.3.6. Oceania

        7.3.7. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Form 

        8.2.3. By End Use Application

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Form 

        8.3.3. By End Use Application

    8.4. Key Takeaways

9. Latin America Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Argentina

            9.2.1.4. Chile

            9.2.1.5. Peru

            9.2.1.6. Rest of Latin America

        9.2.2. By Form 

        9.2.3. By End Use Application

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Form 

        9.3.3. By End Use Application

    9.4. Key Takeaways

10. Europe Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. Italy

            10.2.1.3. France

            10.2.1.4. U.K.

            10.2.1.5. Spain

            10.2.1.6. Russia

            10.2.1.7. BENELUX

            10.2.1.8. Poland

            10.2.1.9. Nordic Countries

            10.2.1.10. Rest of Europe

        10.2.2. By Form 

        10.2.3. By End Use Application

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Form 

        10.3.3. By End Use Application

    10.4. Key Takeaways

11. East Asia Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

        11.2.2. By Form 

        11.2.3. By End Use Application

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Form 

        11.3.3. By End Use Application

    11.4. Key Takeaways

12. South Asia Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Thailand

            12.2.1.3. Malaysia

            12.2.1.4. Indonesia

            12.2.1.5. Rest of South Asia

        12.2.2. By Form 

        12.2.3. By End Use Application

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Form 

        12.3.3. By End Use Application

    12.4. Key Takeaways

13. Oceania Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. Australia

            13.2.1.2. New Zealand

        13.2.2. By Form 

        13.2.3. By End Use Application

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Form 

        13.3.3. By End Use Application

    13.4. Key Takeaways

14. MEA Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Central Africa

            14.2.1.4. North Africa

        14.2.2. By Form 

        14.2.3. By End Use Application

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Form 

        14.3.3. By End Use Application

    14.4. Key Takeaways

15. Key Countries Glucuronolactone Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Form 

            15.1.2.2. By End Use Application

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Form 

            15.2.2.2. By End Use Application

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Form 

            15.3.2.2. By End Use Application

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Form 

            15.4.2.2. By End Use Application

    15.5. Argentina

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Form 

            15.5.2.2. By End Use Application

    15.6. Chile

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Form 

            15.6.2.2. By End Use Application

    15.7. Peru

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Form 

            15.7.2.2. By End Use Application

    15.8. Germany

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Form 

            15.8.2.2. By End Use Application

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Form 

            15.9.2.2. By End Use Application

    15.10. France

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Form 

            15.10.2.2. By End Use Application

    15.11. Spain

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Form 

            15.11.2.2. By End Use Application

    15.12. U.K.

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Form 

            15.12.2.2. By End Use Application

    15.13. Russia

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Form 

            15.13.2.2. By End Use Application

    15.14. Poland

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Form 

            15.14.2.2. By End Use Application

    15.15. BENELUX

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Form 

            15.15.2.2. By End Use Application

    15.16. Nordic Countries

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Form 

            15.16.2.2. By End Use Application

    15.17. China

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Form 

            15.17.2.2. By End Use Application

    15.18. Japan

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Form 

            15.18.2.2. By End Use Application

    15.19. South Korea

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Form 

            15.19.2.2. By End Use Application

    15.20. India

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Form 

            15.20.2.2. By End Use Application

    15.21. Thailand

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2021

            15.21.2.1. By Form 

            15.21.2.2. By End Use Application

    15.22. Indonesia

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2021

            15.22.2.1. By Form 

            15.22.2.2. By End Use Application

    15.23. Malaysia

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2021

            15.23.2.1. By Form 

            15.23.2.2. By End Use Application

    15.24. Singapore

        15.24.1. Pricing Analysis

        15.24.2. Market Share Analysis, 2021

            15.24.2.1. By Form 

            15.24.2.2. By End Use Application

    15.25. GCC Countries

        15.25.1. Pricing Analysis

        15.25.2. Market Share Analysis, 2021

            15.25.2.1. By Form 

            15.25.2.2. By End Use Application

    15.26. South Africa

        15.26.1. Pricing Analysis

        15.26.2. Market Share Analysis, 2021

            15.26.2.1. By Form 

            15.26.2.2. By End Use Application

    15.27. Central Africa

        15.27.1. Pricing Analysis

        15.27.2. Market Share Analysis, 2021

            15.27.2.1. By Form 

            15.27.2.2. By End Use Application

    15.28. North Africa

        15.28.1. Pricing Analysis

        15.28.2. Market Share Analysis, 2021

            15.28.2.1. By Form 

            15.28.2.2. By End Use Application

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Form 

        16.3.3. By End Use Application

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Shaoxing Marina Biotechnology Co.Ltd.

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Hubei Yitai Pharmaceutical Co.Ltd.

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Merck Millipore Corporation

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Anhui Fubore Pharmaceutical & Chemical Co.Ltd.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Functional Food chem International Corporation

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Jungbunzlauer

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Shandong Fuyuan Bio-Tech CO.LTD.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. Roquette Frères

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Shandong Xinhong Pharmaceutical Co., Ltd.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. Shandong Baisheng Biotechnology Co., Ltd.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

        17.1.11. Ceto Coorporation

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

                17.1.11.5.2. Product Strategy

                17.1.11.5.3. Channel Strategy

        17.1.12. Creative Compound

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

                17.1.12.5.2. Product Strategy

                17.1.12.5.3. Channel Strategy

        17.1.13. Foodchem International

            17.1.13.1. Overview

            17.1.13.2. Product Portfolio

            17.1.13.3. Profitability by Market Segments

            17.1.13.4. Sales Footprint

            17.1.13.5. Strategy Overview

                17.1.13.5.1. Marketing Strategy

                17.1.13.5.2. Product Strategy

                17.1.13.5.3. Channel Strategy

        17.1.14. Merck Millipore

            17.1.14.1. Overview

            17.1.14.2. Product Portfolio

            17.1.14.3. Profitability by Market Segments

            17.1.14.4. Sales Footprint

            17.1.14.5. Strategy Overview

                17.1.14.5.1. Marketing Strategy

                17.1.14.5.2. Product Strategy

                17.1.14.5.3. Channel Strategy

        17.1.15. Others (on additional request)

            17.1.15.1. Overview

            17.1.15.2. Product Portfolio

            17.1.15.3. Profitability by Market Segments

            17.1.15.4. Sales Footprint

            17.1.15.5. Strategy Overview

                17.1.15.5.1. Marketing Strategy

                17.1.15.5.2. Product Strategy

                17.1.15.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

 

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Glucuronolactone Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Glucuronolactone Volume (MT) Forecast by Region, 2017-2032

Table 3: Global Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032

Table 4: Global Glucuronolactone Volume (MT) Forecast By Form , 2017-2032

Table 5: Global Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032

Table 6: Global Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032

Table 7: North America Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032

Table 8: North America Glucuronolactone Volume (MT) Forecast by Country, 2017-2032

Table 9: North America Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032

Table 10: North America Glucuronolactone Volume (MT) Forecast By Form , 2017-2032

Table 11: North America Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032

Table 12: North America Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032

Table 13: Latin America Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Latin America Glucuronolactone Volume (MT) Forecast by Country, 2017-2032

Table 15: Latin America Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032

Table 16: Latin America Glucuronolactone Volume (MT) Forecast By Form , 2017-2032

Table 17: Latin America Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032

Table 18: Latin America Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032

Table 19: Europe Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032

Table 20: Europe Glucuronolactone Volume (MT) Forecast by Country, 2017-2032

Table 21: Europe Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032

Table 22: Europe Glucuronolactone Volume (MT) Forecast By Form , 2017-2032

Table 23: Europe Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032

Table 24: Europe Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032

Table 25: East Asia Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032

Table 26: East Asia Glucuronolactone Volume (MT) Forecast by Country, 2017-2032

Table 27: East Asia Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032

Table 28: East Asia Glucuronolactone Volume (MT) Forecast By Form , 2017-2032

Table 29: East Asia Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032

Table 30: East Asia Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032

Table 31: South Asia Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032

Table 32: South Asia Glucuronolactone Volume (MT) Forecast by Country, 2017-2032

Table 33: South Asia Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032

Table 34: South Asia Glucuronolactone Volume (MT) Forecast By Form , 2017-2032

Table 35: South Asia Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032

Table 36: South Asia Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032

Table 37: Oceania Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032

Table 38: Oceania Glucuronolactone Volume (MT) Forecast by Country, 2017-2032

Table 39: Oceania Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032

Table 40: Oceania Glucuronolactone Volume (MT) Forecast By Form , 2017-2032

Table 41: Oceania Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032

Table 42: Oceania Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032

Table 43: MEA Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032

Table 44: MEA Glucuronolactone Volume (MT) Forecast by Country, 2017-2032

Table 45: MEA Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032

Table 46: MEA Glucuronolactone Volume (MT) Forecast By Form , 2017-2032

Table 47: MEA Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032

Table 48: MEA Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032

Nandini Roy Choudhury
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Glucuronolactone Value (US$ Mn) By Form , 2022-2032

Figure 2: Global Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032

Figure 3: Global Glucuronolactone Value (US$ Mn) by Region, 2022-2032

Figure 4: Global Glucuronolactone Value (US$ Mn) Analysis by Region, 2017-2032

Figure 5: Global Glucuronolactone Volume (MT) Analysis by Region, 2017-2032

Figure 6: Global Glucuronolactone Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Glucuronolactone Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032

Figure 9: Global Glucuronolactone Volume (MT) Analysis By Form , 2017-2032

Figure 10: Global Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032

Figure 11: Global Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032

Figure 12: Global Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032

Figure 13: Global Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032

Figure 14: Global Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032

Figure 15: Global Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032

Figure 16: Global Glucuronolactone Attractiveness By Form , 2022-2032

Figure 17: Global Glucuronolactone Attractiveness by End Use Application, 2022-2032

Figure 18: Global Glucuronolactone Attractiveness by Region, 2022-2032

Figure 19: North America Glucuronolactone Value (US$ Mn) By Form , 2022-2032

Figure 20: North America Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032

Figure 21: North America Glucuronolactone Value (US$ Mn) by Country, 2022-2032

Figure 22: North America Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032

Figure 23: North America Glucuronolactone Volume (MT) Analysis by Country, 2017-2032

Figure 24: North America Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 25: North America Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 26: North America Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032

Figure 27: North America Glucuronolactone Volume (MT) Analysis By Form , 2017-2032

Figure 28: North America Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032

Figure 29: North America Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032

Figure 30: North America Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032

Figure 31: North America Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032

Figure 32: North America Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032

Figure 33: North America Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032

Figure 34: North America Glucuronolactone Attractiveness By Form , 2022-2032

Figure 35: North America Glucuronolactone Attractiveness by End Use Application, 2022-2032

Figure 36: North America Glucuronolactone Attractiveness by Country, 2022-2032

Figure 37: Latin America Glucuronolactone Value (US$ Mn) By Form , 2022-2032

Figure 38: Latin America Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032

Figure 39: Latin America Glucuronolactone Value (US$ Mn) by Country, 2022-2032

Figure 40: Latin America Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032

Figure 41: Latin America Glucuronolactone Volume (MT) Analysis by Country, 2017-2032

Figure 42: Latin America Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 43: Latin America Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 44: Latin America Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032

Figure 45: Latin America Glucuronolactone Volume (MT) Analysis By Form , 2017-2032

Figure 46: Latin America Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032

Figure 47: Latin America Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032

Figure 48: Latin America Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032

Figure 49: Latin America Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032

Figure 50: Latin America Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032

Figure 51: Latin America Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032

Figure 52: Latin America Glucuronolactone Attractiveness By Form , 2022-2032

Figure 53: Latin America Glucuronolactone Attractiveness by End Use Application, 2022-2032

Figure 54: Latin America Glucuronolactone Attractiveness by Country, 2022-2032

Figure 55: Europe Glucuronolactone Value (US$ Mn) By Form , 2022-2032

Figure 56: Europe Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032

Figure 57: Europe Glucuronolactone Value (US$ Mn) by Country, 2022-2032

Figure 58: Europe Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032

Figure 59: Europe Glucuronolactone Volume (MT) Analysis by Country, 2017-2032

Figure 60: Europe Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 61: Europe Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 62: Europe Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032

Figure 63: Europe Glucuronolactone Volume (MT) Analysis By Form , 2017-2032

Figure 64: Europe Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032

Figure 65: Europe Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032

Figure 66: Europe Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032

Figure 67: Europe Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032

Figure 68: Europe Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032

Figure 69: Europe Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032

Figure 70: Europe Glucuronolactone Attractiveness By Form , 2022-2032

Figure 71: Europe Glucuronolactone Attractiveness by End Use Application, 2022-2032

Figure 72: Europe Glucuronolactone Attractiveness by Country, 2022-2032

Figure 73: East Asia Glucuronolactone Value (US$ Mn) By Form , 2022-2032

Figure 74: East Asia Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032

Figure 75: East Asia Glucuronolactone Value (US$ Mn) by Country, 2022-2032

Figure 76: East Asia Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032

Figure 77: East Asia Glucuronolactone Volume (MT) Analysis by Country, 2017-2032

Figure 78: East Asia Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 79: East Asia Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 80: East Asia Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032

Figure 81: East Asia Glucuronolactone Volume (MT) Analysis By Form , 2017-2032

Figure 82: East Asia Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032

Figure 83: East Asia Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032

Figure 84: East Asia Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032

Figure 85: East Asia Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032

Figure 86: East Asia Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032

Figure 87: East Asia Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032

Figure 88: East Asia Glucuronolactone Attractiveness By Form , 2022-2032

Figure 89: East Asia Glucuronolactone Attractiveness by End Use Application, 2022-2032

Figure 90: East Asia Glucuronolactone Attractiveness by Country, 2022-2032

Figure 91: South Asia Glucuronolactone Value (US$ Mn) By Form , 2022-2032

Figure 92: South Asia Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032

Figure 93: South Asia Glucuronolactone Value (US$ Mn) by Country, 2022-2032

Figure 94: South Asia Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032

Figure 95: South Asia Glucuronolactone Volume (MT) Analysis by Country, 2017-2032

Figure 96: South Asia Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 97: South Asia Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 98: South Asia Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032

Figure 99: South Asia Glucuronolactone Volume (MT) Analysis By Form , 2017-2032

Figure 100: South Asia Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032

Figure 101: South Asia Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032

Figure 102: South Asia Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032

Figure 103: South Asia Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032

Figure 104: South Asia Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032

Figure 105: South Asia Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032

Figure 106: South Asia Glucuronolactone Attractiveness By Form , 2022-2032

Figure 107: South Asia Glucuronolactone Attractiveness by End Use Application, 2022-2032

Figure 108: South Asia Glucuronolactone Attractiveness by Country, 2022-2032

Figure 109: Oceania Glucuronolactone Value (US$ Mn) By Form , 2022-2032

Figure 110: Oceania Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032

Figure 111: Oceania Glucuronolactone Value (US$ Mn) by Country, 2022-2032

Figure 112: Oceania Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032

Figure 113: Oceania Glucuronolactone Volume (MT) Analysis by Country, 2017-2032

Figure 114: Oceania Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 115: Oceania Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 116: Oceania Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032

Figure 117: Oceania Glucuronolactone Volume (MT) Analysis By Form , 2017-2032

Figure 118: Oceania Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032

Figure 119: Oceania Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032

Figure 120: Oceania Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032

Figure 121: Oceania Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032

Figure 122: Oceania Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032

Figure 123: Oceania Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032

Figure 124: Oceania Glucuronolactone Attractiveness By Form , 2022-2032

Figure 125: Oceania Glucuronolactone Attractiveness by End Use Application, 2022-2032

Figure 126: Oceania Glucuronolactone Attractiveness by Country, 2022-2032

Figure 127: MEA Glucuronolactone Value (US$ Mn) By Form , 2022-2032

Figure 128: MEA Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032

Figure 129: MEA Glucuronolactone Value (US$ Mn) by Country, 2022-2032

Figure 130: MEA Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032

Figure 131: MEA Glucuronolactone Volume (MT) Analysis by Country, 2017-2032

Figure 132: MEA Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 133: MEA Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 134: MEA Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032

Figure 135: MEA Glucuronolactone Volume (MT) Analysis By Form , 2017-2032

Figure 136: MEA Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032

Figure 137: MEA Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032

Figure 138: MEA Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032

Figure 139: MEA Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032

Figure 140: MEA Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032

Figure 141: MEA Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032

Figure 142: MEA Glucuronolactone Attractiveness By Form , 2022-2032

Figure 143: MEA Glucuronolactone Attractiveness by End Use Application, 2022-2032

Figure 144: MEA Glucuronolactone Attractiveness by Country, 2022-2032

 

Need specific information?

Request Customization

Explore Food and Beverage Insights

View Reports

Recommendations

Food and Beverage

Food and Beverages Additives Market

Published : March 2022

Food and Beverage

Food Additives Market

Published : January 2017

Food and Beverage

GCC Functional Food Market

Published : December 2014

Google translate

Glucuronolactone Market